The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
Alejandro Schcolnik‐Cabrera(Instituto Nacional de Cancerología), Alfonso Dueñas‐González(Instituto Nacional de Cancerología)
Cited by 16
Related Papers
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
|Journal of Clinical Oncology|2011|479
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
|Cancer Cell International|2006|35